Bunsua, Merly L.

HRN: 29-05-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2026
06/27/2026
IV
600mg
Q6hrs
Breast Mass Left
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines